Results 281 to 290 of about 2,439,563 (414)

MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? [PDF]

, 2019
Accurso, V., Cordova, A., Di Piazza, F., Di Stefano, A. B., Lo Re, J., Mancuso, S., Russo, A., Santoro, M., Siragusa, S.   +8 more
core   +1 more source

Expression of Matrix Metalloproteinases in Thyroid Follicular Neoplasm Fnab

, 2020
Meta Zulyati Oktora, Meta Zulyati Oktora, Anandia Putriyuni   +2 more
openalex   +2 more sources

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Myeloid Mir34a suppresses initiation and progression of intestinal and colitis-induced colon cancers in APC^min mice. [PDF]

Cell Death Dis
Chen Y, Liu F, König J, Bouznad N, Hermeking H.   +4 more
europepmc   +1 more source

Prevalence of Gastric and Duodenal Polyps and Risk Factors for Duodenal Neoplasm in Korean Patients with Familial Adenomatous Polyposis

, 2011
So Youn Park, Ji Kon Ryu, Ju Hee Park, Hyuk Yoon, Ji Yeon Kim, Yong Bum Yoon, Jae‐Gahb Park, Sang Hyub Lee, Sung‐Bum Kang, Ji Won Park, Jae Hwan Oh   +10 more
openalex   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

A case series of primary urinary tract neuroendocrine neoplasms. [PDF]

Front Oncol
Zheng Y, Wang W, Zhou Y, Zhu M, Jiang Z, Wang Y, Shi B, Zhu Y.   +7 more
europepmc   +1 more source

PARP inhibitors induce a senescence phenotype in non‐small cell lung carcinoma cell lines

FEBS Open Bio, EarlyView.
Talazoparib is the most potent inducer of senescence among different PARP1 inhibitors in human NSCLC cells. In the absence of PARP, no senescence phenotype was observed, demonstrating that PARP1 is necessary for the induction of senescence by this inhibitor.
Camille Huart, Manon Van den Abbeel, Christoph Schifflers, Karim Bouhjar, Andrea Scarmelotto, Alexis Khelfi, Anne‐Catherine Wera, Carine Michiels   +7 more
wiley   +1 more source

National mortality trends associated with the death certificate-reported co-occurrence of malignant neoplasms and bacterial diseases in the United States, 1999-2023: a CDC WONDER retrospective analysis. [PDF]

Ann Med Surg (Lond)
Asghar P, Safwan MS, Rehman A, Lodh S, Sheikh M, Kamil KA.   +5 more
europepmc   +1 more source

Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms.

, 1981
Maria A. Cifone, Isaiah J. Fidler
openalex   +2 more sources